1. Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer
    Yongkuan Cao et al, 2017, BMC Gastroenterology CrossRef
  2. Bioinformatics analysis reveals 6 key biomarkers associated with non-small-cell lung cancer
    Bai Dai et al, 2020, Journal of International Medical Research CrossRef
  3. Suppression of PTEN/AKT signaling decreases the expression of TUBB3 and TOP2A with subsequent inhibition of cell growth and induction of apoptosis in human breast cancer MCF-7 cells via ATP and caspase-3 signaling pathways
    Zhenhua Yang et al, 2017, Oncology Reports CrossRef
  4. Identification of Gene Markers for Survival Prediction of Lung Adenocarcinoma Patients Based on Integrated Multibody Data Analysis
    Yuwang Bao et al, 2021, Journal of Nanomaterials CrossRef
  5. TYMS presents a novel biomarker for diagnosis and prognosis in patients with pancreatic cancer
    Zhuo Fu et al, 2019, Medicine CrossRef
  6. A gene-based survival score for lung adenocarcinoma by multiple transcriptional datasets analysis
    Yanlu Xiong et al, 2020, BMC Cancer CrossRef
  7. Expression of ERCC1 and TYMS in colorectal cancer patients and the predictive value of chemotherapy efficacy
    Hong Jiang et al, 2019, Oncology Letters CrossRef
  8. Polymorphism rs3819102 in thymidylate synthase and environmental factors: effects on lung cancer in Chinese population
    Wei Feng et al, 2019, Current Problems in Cancer CrossRef
  9. Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non‐small cell lung cancer patients
    Anna Grenda et al, 2020, Cancer Medicine CrossRef
  10. Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer
    Ling Li et al, 2016, International Journal of Molecular Sciences CrossRef
  11. Expression and gene regulation network of TYMS and BCL2L1 in colorectal cancer based on data mining
    Yanghua Jie et al, 2021, PeerJ CrossRef
  12. Diagnostic and prognostic value of thymidylate synthase expression in breast cancer
    Shaoran Song et al, 2021, Clinical and Experimental Pharmacology and Physiology CrossRef
  13. Novel Venetin-1 nanoparticle from earthworm coelomic fluid as a promising agent for the treatment of non-small cell lung cancer
    Magda Rybicka et al, 2022, Scientific Reports CrossRef
  14. Genomic alterations in neuroendocrine cancers of the ovary
    George Yaghmour et al, 2016, Journal of Ovarian Research CrossRef
  15. Extensive analysis of the molecular biomarkers excision repair cross complementing 1, ribonucleotide reductase M1, β-tubulin III, thymidylate synthetase, and topoisomerase IIα in breast cancer
    Juncheng Li et al, 2021, Medicine CrossRef